Navigation Links
Many Americans Enjoying Longer, Healthier Lives Due to Medical Innovation and New Therapies
Date:2/19/2010

WASHINGTON, Feb. 19 /PRNewswire-USNewswire/ -- An article that recently appeared in El Tejano Magazine highlighted the fact that many Americans are living longer, healthier and more productive lives because of medical innovation and research.

America's pharmaceutical research and biotechnology companies are leading the charge. The Congressional Budget Office specifically identified America's biopharmaceutical sector as "one of the most research-intensive industries" in America.

"A strong, innovative and creative pharmaceutical research and biotechnology sector based in the United States is a real boon to American patients," said Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA). "American patients often get access to new and better medicines well ahead of patients around the world, and this homegrown innovation not only saves lives, it helps the American economy by employing millions of Americans and pumping billions of dollars into our local and national economies," Tauzin added.

According to a study recently published in Health Affairs, cancer patients live three years longer on average than in 1980; 83 percent of that gain is the result of new treatments. In addition, there was a nearly 50 percent decline in heart failure- and heart attack-related deaths between 1999 and 2005. The rate of AIDS deaths has fallen by more than 70 percent since highly active anti-retroviral therapies were developed, and blood pressure medicines prevented 86,000 premature deaths from cardiovascular disease and avoided 833,000 hospitalizations for heart attack and stroke in just one year, according to a 2007 study.

These and many other medical advances were driven by U.S.-based medical innovation, according to a recent study by the Tufts Center for the Study of Drug Development. In fact, the study showed that 75 percent of new drugs in recent years were first introduced in the U.S.

"It's important to keep in mind," said Tauzin, "that developing new therapies can be risky, expensive and time consuming. Creating a new medicine, on average, takes between 10 and 15 years and can cost $1.3 billion. But it's an investment biopharmaceutical research companies make because nothing is as important as the search for new cures and treatments that help patients live longer, healthier lives."

SOURCE Pharmaceutical Research and Manufacturers of America

Back to top

RELATED LINKS
http://www.phrma.org

'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Ohio Today
2. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Michigan Today
3. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Massachusetts Today
4. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in North Carolina Today
5. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Missouri Today
6. HearUSA Introduces AARP Hearing Care Program for Americans Aged 50-plus in Pennsylvania Today
7. Consumer Reports Health: Americans With Heartburn Paying Too Much Green For Nexiums Purple Pill
8. Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
9. New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform
10. Alzheimers Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors
11. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
Breaking Medicine News(10 mins):